Clinical Trials Logo

Clinical Trial Summary

Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers


Clinical Trial Description

To healthy volunteers subjects of twenty four(24), following treatments are administered dosing in each period injected wash-out period is a minimum of 7days. Treatment A(Test Drug): Vorico Injection 200mg(Voriconazole) for Single Dose Treatment B(Reference Drug): Vfend® IV 200mg for Single Dose Pharmacokinetic blood samples are collected up to 24hrs.

Safety and pharmacokinetic are assessed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02631954
Study type Interventional
Source Chong Kun Dang Pharmaceutical
Contact
Status Completed
Phase Phase 1
Start date September 2015
Completion date November 2015

See also
  Status Clinical Trial Phase
Completed NCT01782131 - A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) Phase 3
Completed NCT00177684 - Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®) Phase 3
Recruiting NCT01684189 - Registry of Febrile Neutropenia and Invasive Fungal Infections N/A
Completed NCT00794703 - A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections Phase 3
Completed NCT00606268 - A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant Phase 1
Completed NCT00353158 - A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity Phase 1
Completed NCT01777763 - Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615) Phase 1
Recruiting NCT01222741 - Studies of Disorders With Increased Susceptibility to Fungal Infections
Completed NCT02358499 - Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children Phase 1
Completed NCT00177710 - Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study Phase 3
Enrolling by invitation NCT03793231 - fungalAi for Fungal Surveillance & Antifungal Stewardship
Completed NCT02025699 - Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis N/A
Completed NCT01436578 - Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547) N/A
Completed NCT00876096 - Interest of Real-time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal Infections N/A
Completed NCT02306330 - MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial N/A
Not yet recruiting NCT01105013 - Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections Phase 3
Terminated NCT01716234 - A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579) Phase 1
Recruiting NCT05336851 - Emergency PWAS in Respiratory Infectious Disease